Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 294
Filter
1.
Sanid. mil ; 78(4): 279-280, Oct-Dic. 2022. ilus
Article in Spanish | IBECS | ID: ibc-220571

ABSTRACT

Mujer de 57 años con trastorno del espectro autista y crisis epilépticas secundarias que consulta por clínica debida a anemia y pérdida de peso. Como antecedentes más relevantes destaca un ingreso hospitalario por sepsis urinaria, donde se evidenció Morganella morganii y una bacteriemia con aislamiento de Staphylococcus epidermidis. La paciente no refería en el momento de la consulta clínica urinaria.Se realizó un TC de abdomen donde se observa un aumento de tamaño del riñón derecho, con pérdida de la diferenciación córtico-medular y sustitución del parénquima renal normal por masas de baja atenuación en el espesor de un parénquima renal destruido que se corresponden con los cálices dilatados. Todo ello asociado a un cálculo coraliforme con afectación de la grasa peripélvica.(AU)


57-year-old woman with autism spectrum disorder and secondary epileptic seizures. A CT of abdomen is requested due to anemia and weight loss. The patient did not refer urinary symptoms. She was admitted four months to Internal Medicine Service, due to urinary sepsis, where Morganela morgani was isolated, and bacteremia, with Staphylococcus epidermidis isolation.In the CT performed, we found an increase in the size of the right kidney, with loss of corticomedullary differentiation and replacement of a destroyed renal parenchyma by low-attenuation masses that corresponds to the dilated calyces. A staghorn stone with involvement of the peripelvic fat was also described.(AU)


Subject(s)
Humans , Female , Middle Aged , Anemia , Weight Loss , Autism Spectrum Disorder , Seizures , Pyelonephritis, Xanthogranulomatous , Inpatients , Physical Examination
2.
Rev Neurol ; 75(10): 297-303, 2022 11 16.
Article in Spanish | MEDLINE | ID: mdl-36354298

ABSTRACT

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is the most common degenerative motor neuron disease. There is no curative treatment available, and these patients require multidisciplinary support to promote their comfort and quality of life. PATIENTS AND METHODS: Longitudinal descriptive study in patients registered in primary care (PC), Costa de Ponent-Barcelona Institut Catala de la Salut to analyse emergency hospital visits, use of support devices and their integration into the primary care chronicity program. Variables were sex, age and evolution time, emergency visits, patients with percutaneous gastrostomy (PEG), non-invasive or invasive ventilation (NIV/VI), integration in the primary care chronicity program. RESULTS: 81 patients, 49.4% male, mean age 65.6 years (±11.7), evolution time less than 2 years or equal to or greater than 2 years (42 and 58%, respectively). Of them, 47 (58.5%) made 107 consultations. The most frequent reasons for consultation were falls (26.8%), respiratory difficulties (23.3%), comorbidity (16.7%), eating problems (11%) and pain (10.2%) without differences by age or sex. Greater frequency (p < 0.001) was observed in patients with less than two years of evolution and significant increases in the use of NIV and PEG up to 51.9 and 35.8% respectively, as well as integration in primary care chronicity program of 61.7%. CONCLUSIONS: Accidental falls were the most frequent and potentially avoidable reason for hospital emergency visits in patients with ALS, especially in the first two years of the disease. Significant increases are detected in the use of support devices and in primary care chronicity program integration. It is necessary to increase home resources, especially in physiotherapy and occupational therapy.


TITLE: Análisis de las caídas accidentales y la integración en los programas de cronicidad de los pacientes con esclerosis lateral amiotrófica.Introducción. La esclerosis lateral amiotrófica (ELA) es la enfermedad degenerativa de las motoneuronas más frecuente. No dispone de tratamiento curativo y estos pacientes requieren un soporte multidisciplinar para favorecer su confort y calidad de vida. Pacientes y métodos. Estudio descriptivo longitudinal en pacientes registrados en atención primaria, Costa de Ponent-Barcelona, Institut Català de la Salut, para analizar las visitas urgentes hospitalarias, la utilización de dispositivos de soporte y su integración en el programa de atención a la cronicidad. Las variables fueron sexo, edad y tiempo de evolución, visitas urgentes, portadores de gastrostomía percutánea (PEG), ventilación no invasiva o invasiva (VNI/VI) e integración en el programa de atención a la cronicidad. Resultados. Se incluyó a 81 pacientes, un 49,4% varones, con una edad media de 65,6 años (±11,7), y un tiempo de evolución menor de 2 años o igual o mayor de 2 años (42 y 58%, respectivamente). De ellos, 47 (58,5%) realizaron 107 consultas. Los motivos de consulta más frecuentes fueron: caídas (26,8%), dificultades respiratorias (23,3%), comorbilidad (16,7%), problemas en la alimentación (11%) y dolor (10,2%), sin diferencias por edad o sexo. Se observó una mayor frecuentación (p menor de 0,001) en pacientes con menos de dos años de evolución e incrementos significativos en la utilización de la VNI y la PEG hasta el 51,9 y el 35,8%, respectivamente, así como integración en el programa de atención a la cronicidad del 61,7%. Conclusiones. El motivo más frecuente de consulta a urgencias hospitalarias de pacientes con ELA y potencialmente evitable fueron las caídas accidentales, especialmente en los primeros dos años de enfermedad. Se detectan incrementos significativos en la utilización de dispositivos de soporte y en la integración en el programa de atención a la cronicidad. Es necesario incrementar los recursos domiciliarios, especialmente en fisioterapia y terapia ocupacional.


Subject(s)
Amyotrophic Lateral Sclerosis , Motor Neuron Disease , Noninvasive Ventilation , Humans , Male , Aged , Female , Amyotrophic Lateral Sclerosis/therapy , Accidental Falls , Quality of Life
3.
Rev. neurol. (Ed. impr.) ; 75(10): 297-303, Nov 16, 2022. tab, graf
Article in Spanish | IBECS | ID: ibc-211890

ABSTRACT

Introducción: La esclerosis lateral amiotrófica (ELA) es la enfermedad degenerativa de las motoneuronas más frecuente. No dispone de tratamiento curativo y estos pacientes requieren un soporte multidisciplinar para favorecer su confort y calidad de vida. Pacientes y métodos: Estudio descriptivo longitudinal en pacientes registrados en atención primaria, Costa de Ponent-Barcelona, Institut Català de la Salut, para analizar las visitas urgentes hospitalarias, la utilización de dispositivos de soporte y su integración en el programa de atención a la cronicidad. Las variables fueron sexo, edad y tiempo de evolución, visitas urgentes, portadores de gastrostomía percutánea (PEG), ventilación no invasiva o invasiva (VNI/VI) e integración en el programa de atención a la cronicidad. Resultados: Se incluyó a 81 pacientes, un 49,4% varones, con una edad media de 65,6 años (±11,7), y un tiempo de evolución menor de 2 años o igual o mayor de 2 años (42 y 58%, respectivamente). De ellos, 47 (58,5%) realizaron 107 consultas. Los motivos de consulta más frecuentes fueron: caídas (26,8%), dificultades respiratorias (23,3%), comorbilidad (16,7%), problemas en la alimentación (11%) y dolor (10,2%), sin diferencias por edad o sexo. Se observó una mayor frecuentación (p < 0,001) en pacientes con menos de dos años de evolución e incrementos significativos en la utilización de la VNI y la PEG hasta el 51,9 y el 35,8%, respectivamente, así como integración en el programa de atención a la cronicidad del 61,7%. Conclusiones: El motivo más frecuente de consulta a urgencias hospitalarias de pacientes con ELA y potencialmente evitable fueron las caídas accidentales, especialmente en los primeros dos años de enfermedad. Se detectan incrementos significativos en la utilización de dispositivos de soporte y en la integración en el programa de atención a la cronicidad. Es necesario incrementar los recursos domiciliarios, especialmente en fisioterapia y terapia ocupacional.(AU)


Introduction: Amyotrophic lateral sclerosis (ALS) is the most common degenerative motor neuron disease. There is no curative treatment available, and these patients require multidisciplinary support to promote their comfort and quality of life. Patients and methods: Longitudinal descriptive study in patients registered in primary care (PC), Costa de Ponent-Barcelona Institut Català de la Salut to analyse emergency hospital visits, use of support devices and their integration into the primary care chronicity program. Variables were sex, age and evolution time, emergency visits, patients with percutaneous gastrostomy (PEG), non-invasive or invasive ventilation (NIV/VI), integration in the primary care chronicity program. Results: 81 patients, 49.4% male, mean age 65.6 years (±11.7), evolution time less than 2 years or equal to or greater than 2 years (42 and 58%, respectively). Of them, 47 (58.5%) made 107 consultations. The most frequent reasons for consultation were falls (26.8%), respiratory difficulties (23.3%), comorbidity (16.7%), eating problems (11%) and pain (10.2%) without differences by age or sex. Greater frequency (p < 0.001) was observed in patients with less than two years of evolution and significant increases in the use of NIV and PEG up to 51.9 and 35.8% respectively, as well as integration in primary care chronicity program of 61.7%. Conclusions: Accidental falls were the most frequent and potentially avoidable reason for hospital emergency visits in patients with ALS, especially in the first two years of the disease. Significant increases are detected in the use of support devices and in primary care chronicity program integration. It is necessary to increase home resources, especially in physiotherapy and occupational therapy.(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Accidental Falls , Amyotrophic Lateral Sclerosis , Quality of Life , Physical Therapy Specialty , Occupational Therapy , Longitudinal Studies , Epidemiology, Descriptive , Neurology
4.
Rev. esp. anestesiol. reanim ; 69(8): 497-501, Oct. 2022. ilus
Article in Spanish | IBECS | ID: ibc-210290

ABSTRACT

El tromboembolismo venoso (TEV), incluida la trombosis venosa profunda (TVP) y la embolia pulmonar (TEP) es una afección potencialmente letal y a tener en cuenta en mujeres embarazadas, donde la situación es favorecida por los cambios fisiológicos característicos de la gestación, el parto y el puerperio. El manejo de esta patología en este tipo de pacientes está basado en la anticoagulación, con los beneficios e inconvenientes que ello implica. Presentamos el caso de una mujer embarazada con TVP masiva e intentamos arrojar luz sobre temas como son la vía de parto (vaginal vs. cesárea) o el manejo del tratamiento (heparina de bajo peso molecular [HBPM] vs. heparina no fraccionada [HNF]) de cara a obtener la situación más segura para la paciente.(AU)


Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially lethal condition to be taken into account in pregnant women, where the situation is favored by the characteristic physiological changes of the pregnancy, childbirth and the puerperium. The management of this pathology in this type of patient is based on anticoagulation, with the benefits and drawbacks that this implies. We present the case of a pregnant woman with massive DVT and the issues are discussed, such as the method of delivery (vaginal vs. cesarean section) or the management of treatment (LMWH vs. UFH) in order to obtain the safest situation for the patient.(AU)


Subject(s)
Humans , Female , Adult , Pregnant Women , Venous Thrombosis , Cesarean Section , Anesthesia, Obstetrical , Heparin , Anticoagulants , Inpatients , Physical Examination , Symptom Assessment , Echocardiography, Doppler , Anesthesiology , Anesthesia , Cardiopulmonary Resuscitation , Venous Thromboembolism
5.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(8): 497-501, 2022 10.
Article in English | MEDLINE | ID: mdl-36088272

ABSTRACT

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially lethal condition to be taken into account in pregnant women, where the situation is favored by the characteristic physiological changes of the pregnancy, childbirth and the puerperium. The management of this pathology in this type of patient is based on anticoagulation, with the benefits and drawbacks that this implies. We present the case of a pregnant woman with massive DVT and the issues are discussed, such as the method of delivery (vaginal vs. cesarean section) or the management of treatment (LMWH vs. UFH) in order to obtain the safest situation for the patient.


Subject(s)
Heparin, Low-Molecular-Weight , Venous Thrombosis , Anticoagulants/therapeutic use , Cesarean Section , Female , Humans , Pregnancy , Pregnant Women , Venous Thrombosis/etiology
6.
Rev. cir. (Impr.) ; 74(4): 411-414, ago. 2022. ilus
Article in Spanish | LILACS | ID: biblio-1407928

ABSTRACT

Resumen Introducción: La mucormicosis en una enfermedad infrecuente y oportunista que afecta, principalmente, a pacientes inmunocomprometidos. Pocas veces se han reportado casos de afectación periostomal. Clínicamente puede ser confundida con otras patologías, pudiendo tener una evolución fulminante, por lo que un adecuado y pronto diagnóstico son necesarios para una instauración precoz del tratamiento. Caso Clínico: Se presenta el caso de una paciente de 62 años inmunocomprometida, que tras complicaciones quirúrgicas evoluciona con mucormicosis periostomal de la pared abdominal. A pesar de un tratamiento quirúrgico con múltiples resecciones de tejido asociado a antifúngico local y sistémico, la paciente fallece, concordante a la letalidad expresada en la literatura.


Introduction: Mucormycosis is a rare and opportunistic disease that mainly affects immunocompromised patients. Few cases of peristomal involvement have been reported. Clinically it can be confused with other pathologies and may have a fulminant evolution, so an adequate and prompt diagnosis is necessary for an early establishment of treatment. Clinical Case: We present the case of a 62-year-old immunocompromised patient who, after surgical complications, evolves with periostomal mucormycosis of the abdominal wall. Despite surgical treatment with multiple tissue resections, associated with local and systemic antifungal agents, the patient died, consistent with the lethality expressed in the literature.


Subject(s)
Humans , Female , Middle Aged , Abdominal Muscles/pathology , Mucormycosis/pathology , Mucormycosis/drug therapy , Drug Combinations , Mucormycosis/complications , Mucormycosis/microbiology
7.
Antibiotics (Basel) ; 11(6)2022 Jun 17.
Article in English | MEDLINE | ID: mdl-35740220

ABSTRACT

We correlated clinical, epidemiological, microbiological, and genomic data of an outbreak with polymyxin B (PB)- and carbapenem-resistant Klebsiella pneumoniae during the COVID-19 pandemic. Twenty-six PB- and carbapenem-resistant K. pneumoniae were isolated from patients in the COVID-19 ICU (Intensive Care Unit), non-COVID-19 ICU (Intensive Care Unit), clinical, or surgical ward. Bacterial identification, drug susceptibility tests, and DNA sequencing were performed, followed by in silico resistance genes identification. All isolates showed extensively drug-resistant (XDR) phenotypes. Four different sequence types (ST) were detected: ST16, ST11, ST258, and ST437. Nineteen isolates were responsible for an outbreak in the ICU in September 2020. They belong to ST258 and harbored the 42Kb IncX3plasmid (pKP98M3N42) with the same genomic pattern of two K. pneumoniae identified in 2018. Twenty-four isolates carried bla-KPC-2 gene. No plasmid-mediated colistin (mcr) resistance genes were found. Eight isolates presented mgrB gene mutation. The clonal isolates responsible for the outbreak came from patients submitted to pronation, with high mortality rates in one month. XDR-K. pneumoniae detected during the outbreak presented chromosomal resistance to PB and plasmid-acquired carbapenem resistance due to KPC production in most isolates and 42Kb IncX3(pKP98M3N42) plasmid carrying blaKPC-2 was associated with ST258 isolates. The outbreak followed the collapse of the local healthcare system with high mortality rates.

8.
Rev Neurol ; 74(12): 392-402, 2022 06 16.
Article in English, Spanish | MEDLINE | ID: mdl-35698434

ABSTRACT

INTRODUCTION: Huntington's disease (HD) is a degeneration of the brain. OBJECTIVE: To assess the evidence of the physical activity (PA) to improve motor function, gait speed, and walking endurance in individuals with HD. MATERIALS AND METHODS: Two reviewers independently screened references and selected relevant studies to identify randomized controlled trials (RCT), from MEDLINE/PubMed, CENTRAL, PEDro, Scopus, CINAHL, Web of Science databases from inception to September 2021. Two reviewers evaluated risk of bias by the PEDro scale. The primary outcome was assessed motor function, gait speed and walking endurance as a secondary outcome was evaluated activities of daily living (ADL), lower limb functionality strenght, balance, mobility and cognition function in HD. RESULTS: Eight RCT were finally included (231 individuals). Forest plots showed a positive effect for gait endurance, the mean difference (MD) was 17.40 (95% CI from 5.40 to 29.35; p = 0.004), the MD lower limb functionality strength was 1.76 (95% CI from 0.18 to 3.33; p = 0.03) favoring PA group and the MD cognition function was 1.83 (95% CI from 0.50 to 3.16; p = 0.007). No benefits were found for motor function, gait speed, ADL, balance and mobility. CONCLUSIONS: Positive effects of programs PA were observed for walking endurance lower limb functionality strenght and cognition function in low and moderate stage of HD. However, no benefits were found for motor function, gait speed, ADL, balance and mobility. All authors included aerobic exercises in their programs but is unclear if vigorous and intensive PA is optimal for individuals with HD.


TITLE: ¿La actividad física mejora la función motora y la marcha en la enfermedad de Huntington? Una revisión sistemática y metaanálisis.Introducción. La enfermedad de Huntington (EH) es una degeneración del cerebro. Objetivos. Evaluar la evidencia de la actividad física (AF) para mejorar la función motora y la marcha en las personas con EH. Materiales y métodos. Dos revisores examinaron de forma independiente las referencias y seleccionaron ensayos controlados aleatorizados en Medline/PubMed, CENTRAL, PEDro, Scopus, CINAHL y Web of Science desde el inicio hasta septiembre de 2021 y evaluaron el riesgo de sesgo mediante la escala PEDro. Las variables principales fueron la función motora y la marcha, y las secundarias, las actividades de la vida diaria (AVD), la funcionalidad (extremidades inferiores), el equilibrio, la movilidad y la función cognitiva en la EH. Resultados. Se incluyeron ocho ensayos controlados aleatorizados (231 individuos). Se observó un efecto positivo para la resistencia en la marcha, la diferencia de medias fue de 17,4 (intervalo de confianza al 95%: 5,4-29,35; p = 0,004), la diferencia de medias para la funcionalidad (extremidades inferiores) fue de 1,76 (intervalo de confianza al 95%: 0,18-3,33; p = 0,03) y la diferencia de medias para la función cognitiva fue de 1,83 (intervalo de confianza al 95%: 0,5-3,16; p = 0,007) a favor del grupo de AF. No se encontraron beneficios para la función motora, la velocidad de marcha, las AVD, el equilibrio y la movilidad. Conclusiones. Los programas de AF mejoran la resistencia en la marcha, la función cognitiva y la funcionalidad (extremidades inferiores) en la EH. Sin embargo, no se observaron efectos positivos para la función motora, la velocidad de la marcha, las AVD, el equilibrio y la movilidad. Todos los autores incluyeron ejercicios aeróbicos en sus programas, pero no está claro si la AF vigorosa e intensiva es óptima para las personas con EH.


Subject(s)
Huntington Disease , Stroke Rehabilitation , Exercise , Gait , Humans , Huntington Disease/therapy , Walking Speed
9.
Rev. neurol. (Ed. impr.) ; 74(12): 392-402, Jun 16, 2022. ilus, tab, graf
Article in Spanish | IBECS | ID: ibc-217711

ABSTRACT

Objetivos: Evaluar la evidencia de la actividad física (AF) para mejorar la función motora y la marcha en las personas con EH. Materiales y métodos: Dos revisores examinaron de forma independiente las referencias y seleccionaron ensayos controlados aleatorizados en Medline/PubMed, CENTRAL, PEDro, Scopus, CINAHL y Web of Science desde el inicio hasta septiembre de 2021 y evaluaron el riesgo de sesgo mediante la escala PEDro. Las variables principales fueron la función motora y la marcha, y las secundarias, las actividades de la vida diaria (AVD), la funcionalidad (extremidades inferiores), el equilibrio, la movilidad y la función cognitiva en la EH. Resultados: Se incluyeron ocho ensayos controlados aleatorizados (231 individuos). Se observó un efecto positivo para la resistencia en la marcha, la diferencia de medias fue de 17,4 (intervalo de confianza al 95%: 5,4-29,35; p = 0,004), la diferencia de medias para la funcionalidad (extremidades inferiores) fue de 1,76 (intervalo de confianza al 95%: 0,18-3,33; p = 0,03) y la diferencia de medias para la función cognitiva fue de 1,83 (intervalo de confianza al 95%: 0,5-3,16; p = 0,007) a favor del grupo de AF. No se encontraron beneficios para la función motora, la velocidad de marcha, las AVD, el equilibrio y la movilidad. Conclusiones: Los programas de AF mejoran la resistencia en la marcha, la función cognitiva y la funcionalidad (extremidades inferiores) en la EH. Sin embargo, no se observaron efectos positivos para la función motora, la velocidad de la marcha, las AVD, el equilibrio y la movilidad. Todos los autores incluyeron ejercicios aeróbicos en sus programas, pero no está claro si la AF vigorosa e intensiva es óptima para las personas con EH.(AU)


Introduction: Huntington’s disease (HD) is a degeneration of the brain. Objective: To assess the evidence of the physical activity (PA) to improve motor function, gait speed, and walking endurance in individuals with HD. Materials and methods: Two reviewers independently screened references and selected relevant studies to identify randomized controlled trials (RCT), from MEDLINE/PubMed, CENTRAL, PEDro, Scopus, CINAHL, Web of Science databases from inception to September 2021. Two reviewers evaluated risk of bias by the PEDro scale. The primary outcome was assessed motor function, gait speed and walking endurance as a secondary outcome was evaluated activities of daily living (ADL), lower limb functionality strenght, balance, mobility and cognition function in HD. Results: Eight RCT were finally included (231 individuals). Forest plots showed a positive effect for gait endurance, the mean difference (MD) was 17.40 (95% CI from 5.40 to 29.35; p = 0.004), the MD lower limb functionality strength was 1.76 (95% CI from 0.18 to 3.33; p = 0.03) favoring PA group and the MD cognition function was 1.83 (95% CI from 0.50 to 3.16; p = 0.007). No benefits were found for motor function, gait speed, ADL, balance and mobility. Conclusions: Positive effects of programs PA were observed for walking endurance lower limb functionality strenght and cognition function in low and moderate stage of HD. However, no benefits were found for motor function, gait speed, ADL, balance and mobility. All authors included aerobic exercises in their programs but is unclear if vigorous and intensive PA is optimal for individuals with HD.(AU)


Subject(s)
Humans , Huntington Disease , Motor Activity , Gait , Movement Disorders , Stroke , Chorea , Neurology
10.
Andes Pediatr ; 93(1): 99-104, 2022 Feb.
Article in Spanish | MEDLINE | ID: mdl-35506782

ABSTRACT

INTRODUCTION: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition with alterations in social inte raction and communication, and restricted and repetitive patterns of behavior and interests. Gender Dysphoria (GD) refers to the incongruence between the gender identity and the sex assigned at birth, together with a strong and persistent desire to be of the opposite sex. During global personal identity construction, the development of sexual identity is essential. OBJECTIVE: To analyze an adolescent clinical case of co-occurrence of ASD and GD from a psychodynamic understanding of his identity. CLINICAL CASE: A 15-year-old male diagnosed with ASD and borderline intellectual capacity. He mani fested feminine behaviors and interests in girlish games since preschool age, imitating female figures, and verbalizing the desire to be of the opposite sex. A multidisciplinary evaluation of the patient concluded that he presented a diffuse general identity with ambivalent gender identity. Therefore, he did not fulfill the requirements for hormone therapy. Psychological therapy was suggested to favor grea ter exploration and cognitive flexibility to develop a better-defined gender identity. CONCLUSIONS: In cases as ASD, where identity development is compromised, the affected subject often delays or does not consolidate sexual identity, leading to a diffusion of identity and gender, as in the reported case. The co-occurrence of ASD and GD requires a multidisciplinary evaluation that includes a complete assessment of the patient's global identity before considering any definitive therapeutic orientation regarding gender.


Subject(s)
Autism Spectrum Disorder , Gender Dysphoria , Adolescent , Autism Spectrum Disorder/complications , Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/therapy , Child, Preschool , Communication , Female , Gender Dysphoria/psychology , Gender Dysphoria/therapy , Gender Identity , Humans , Infant, Newborn , Male , Schools
11.
Bioinspir Biomim ; 17(4)2022 05 19.
Article in English | MEDLINE | ID: mdl-35447617

ABSTRACT

Experimental and numerical results are reported for the internal and external flow fields evolving in a bio-inspired snapping plunger. The experimental evidence underlines the nature of the dynamic-coupling between the processes taking place inside and outside the device. Two main structures dictate the properties of the external flow field: a strong jet which is followed by a vortex ring. Internally, complex patterns of cavitating structures are simultaneously produced in the chamber and the venturi-like conduit. We find the cavitation cycle to be suitably described by the Rayleigh-Plesset model and, thus, proceed to characterize the coupling of both fields in terms of the fluctuations of the velocity. All main parameters, as well as the energy released to the fluid during the collapse, are found to be within the same order-of-magnitude of previously known experimental results for isolated bubbles of comparable size.


Subject(s)
Hydrodynamics
12.
Emerg Infect Dis ; 28(3): 730-733, 2022 03.
Article in English | MEDLINE | ID: mdl-35133956

ABSTRACT

We conducted a prospective cohort study in a population with diverse ethnic backgrounds from Brazil to assess clinically meaningful symptoms after surviving coronavirus disease. For most of the 175 patients in the study, clinically meaningful symptoms, including fatigue, dyspnea, cough, headache, and muscle weakness, persisted for >120 days after disease onset.


Subject(s)
COVID-19 , Brazil/epidemiology , Humans , Prospective Studies , SARS-CoV-2 , Survivors
13.
RMD Open ; 7(1)2021 02.
Article in English | MEDLINE | ID: mdl-33542047

ABSTRACT

OBJECTIVE: To evaluate whether the addition of colchicine to standard treatment for COVID-19 results in better outcomes. DESIGN: We present the results of a randomised, double-blinded, placebo-controlled clinical trial of colchicine for the treatment of moderate to severe COVID-19, with 75 patients allocated 1:1 from 11 April to 30 August 2020. Colchicine regimen was 0.5 mg thrice daily for 5 days, then 0.5 mg twice daily for 5 days. The primary endpoints were the need for supplemental oxygen, time of hospitalisation, need for admission and length of stay in intensive care unit and death rate. RESULTS: Seventy-two patients (36 for placebo and 36 for colchicine) completed the study. Median (and IQR) time of need for supplemental oxygen was 4.0 (2.0-6.0) days for the colchicine group and 6.5 (4.0-9.0) days for the placebo group (p<0.001). Median (IQR) time of hospitalisation was 7.0 (5.0-9.0) days for the colchicine group and 9.0 (7.0-12.0) days for the placebo group (p=0.003). At day 2, 67% versus 86% of patients maintained the need for supplemental oxygen, while at day 7, the values were 9% versus 42%, in the colchicine and the placebo groups, respectively (log rank; p=0.001). Two patients died, both in placebo group. Diarrhoea was more frequent in the colchicine group (p=0.26). CONCLUSION: Colchicine reduced the length of both, supplemental oxygen therapy and hospitalisation. The drug was safe and well tolerated. Once death was an uncommon event, it is not possible to ensure that colchicine reduced mortality of COVID-19. TRIAL REGISTRATION NUMBER: RBR-8jyhxh.


Subject(s)
COVID-19 Drug Treatment , Colchicine/administration & dosage , Length of Stay , Oxygen Inhalation Therapy , SARS-CoV-2/genetics , Severity of Illness Index , Adult , Aged , COVID-19/mortality , COVID-19/virology , Colchicine/adverse effects , Diarrhea/chemically induced , Double-Blind Method , Female , Humans , Intensive Care Units , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Treatment Outcome
14.
Rev. chil. obstet. ginecol. (En línea) ; 86(1): 104-119, feb. 2021. ilus, tab
Article in Spanish | LILACS | ID: biblio-1388624

ABSTRACT

INTRODUCCIÓN Y OBJETIVOS: El embarazo en cicatriz de cesárea previa (ECC) es una entidad poco frecuente que puede tener graves consecuencias. Hasta la fecha no existen esquemas estandarizados de tratamiento y su manejo óptimo sigue siendo controvertido. Nuestro objetivo es realizar una revisión de la literatura publicada sobre el manejo del ECC y proponer un algoritmo. También exponemos tres casos de ECC resueltos con diferentes tratamientos en el Hospital Universitario Infanta Elena MÉTODOS: Búsqueda de la literatura en bases de datos utilizando las palabras clave: "embarazo en cicatriz cesárea"," gestación ectópica en cicatriz cesárea", "tratamiento", "manejo". RESULTADOS: Las opciones terapéuticas pueden ser médicas, quirúrgicas o una combinación de ambas. Los tratamientos quirúrgicos tienen altas tasas de éxito, sin embargo, son más invasivos y no están exentos de riesgo. La combinación de tratamientos parece aumentar la tasa de éxito, no obstante, podría implicar un mayor riesgo de efectos secundarios y costes. CONCLUSIONES: El manejo de los ECC debe de ser individualizado, basado en la evidencia científica, en los medios disponibles y la experiencia de los profesionales en los distintos procedimientos, guiándonos por el tipo de ECC y su grado de vascularización e invasión, grosor del miometrio, niveles de beta-hCG, presencia de actividad cardiaca, clínica y estabilidad hemodinámica de la paciente. Deben tenerse en cuenta las circunstancias y patología intercurrente de la mujer, así como su deseo genésico o de preservación del útero.


INTRODUCTION AND OBJECTIVES: Cesarean scar pregnancy (CSP) is a rare entity that can cause serious consequences. Up to now, there are no standardized treatment schemes, and its optimal management remains controversial. Our objetive is to review the literature regarding CSP management and propose an algorithm. We also present three cases of CSP resolved with different treatments at Hospital Universitario Infanta Elena. METHODS: Literature search in databases using the following keywords: pregnancy with cesarean section, ectopic pregnancy with cesarean section, treatment, management. RESULTS: The therapeutic options can be medical, surgical or a combination of both. Surgical treatments have high success rates; however, they are more invasive and are not without risk. The combination of treatments seems to increase the success rate; however, it could imply a higher risk of side effects and costs. CONCLUSIONS: The management of CSP must be individualized; based on scientific evidence, on the means available, and on the experience of the professionals in the different procedures; guided by the type of CSP and its degree of vascularization and invasion, by the thickness of the myometrium, beta-hCG levels, presence of cardiac activity, and by clinical and hemodynamic stability of the patient. The circumstances and intercurrent pathology of the patient must be considered, as well as her desire for future pregnancy or preservation of the uterus.


Subject(s)
Humans , Female , Pregnancy , Adult , Pregnancy, Ectopic/therapy , Cesarean Section/adverse effects , Cicatrix/etiology , Cicatrix/therapy , Pregnancy, Ectopic/surgery , Pregnancy, Ectopic/drug therapy , Methotrexate/therapeutic use , Cicatrix/surgery , Cicatrix/drug therapy , Uterine Artery Embolization , High-Intensity Focused Ultrasound Ablation , Hysterectomy
15.
Eur J Sport Sci ; 21(3): 450-459, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32349629

ABSTRACT

The aim of the study was to compare the impact of 12-week resistance training with blood flow restriction (GRTBFR) versus, traditional resistance training (GTRT) and non-training on the muscle strength and body composition HIV/AIDS participants. Muscle strength was tested at baseline, and on the 6th, 21st and 36th training sessions, using maximal repetition test. Pre- and post-intervention body composition changes were measured by dual-energy X-ray absorptiometry. Resistance training was undertaken three times a week comprising bilateral elbow extension and flexion exercises, unilateral flexion and bilateral knee extension. Changes in strength and body composition (pre- and post-intervention) between groups were evaluated by mixed models of repeated measures, and by paired and unpaired comparisons, considering the Effect Size. All groups were similar at baseline for muscle strength and body composition. Post-intervention, the training groups showed similar, statistically significant increases in muscle strength (GRTBFR=25.7-57.4%; GTRT=24.5-52.3%) and skeletal muscle tissue (GRTBFR=8.4%; GTRT=8.3%). There was also a significant change in body fat (p=0.023-0.043), with significant effect sizes for strength and skeletal muscle tissue (0.41-2.27), respectively. These results suggest that both resistance training interventions promoted muscle hypertrophy, body fat reduction and positive impact on muscle strength in people living with HIV/AIDS. Resistance training with blood flow restriction proved to be an effective alternative to include patients with marked physical weakness, unable to engage in regular strength training programme.ClinicalTrials.gov identifier: NCT02783417.


Subject(s)
Body Composition/physiology , HIV Infections/physiopathology , Muscle Strength/physiology , Resistance Training/methods , Absorptiometry, Photon , Adipose Tissue/anatomy & histology , Adult , Female , Humans , Male , Middle Aged , Muscle, Skeletal/anatomy & histology , Regional Blood Flow/physiology , Tibial Arteries/physiology , Time Factors
16.
Int J Med Microbiol ; 310(7): 151451, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33092695

ABSTRACT

Cystic fibrosis (CF) is a disease characterized by bacterial chronic infection of the respiratory tract and inflammation, which leads to a progressive decrease in lung function. Pseudomonas aeruginosa is commonly isolated from the sputum of patients and their presence is associated with a predominant airway inflammation with neutrophils, causing chronic colonization and higher mortality rates. Neutrophil extracellular traps (NETs) have been observed in response against Pseudomonas, however, these cannot eliminate the pathogen from the respiratory tract, so one possibility is that the bacteria could promote their production to use them as a scaffold to colonize the lungs and as a nutrient source, however, their overproduction could also lead to increased damage to the lungs. In this work, we evaluated NETs formation by Pseudomonas clinical isolates obtained from CF patients and found that these induced NETs formation with globular or spread morphologies, of note, we found that there is a trend by which the spread forms were induced mainly by isolates obtained from patients with severe disease, whereas, the globular morphologies were observed for isolates obtained from patients with mild/moderate disease. Finally, we screened for bacterial molecules implicated in NETs formation and found that Exotoxin S, pyocin S2 and pyoverdine could participate in the process.


Subject(s)
Cystic Fibrosis , Extracellular Traps , Pseudomonas Infections , Pseudomonas aeruginosa , Cystic Fibrosis/complications , Humans , Neutrophils , Severity of Illness Index
17.
J Exp Med ; 217(12)2020 12 07.
Article in English | MEDLINE | ID: mdl-32926098

ABSTRACT

Severe COVID-19 patients develop acute respiratory distress syndrome that may progress to cytokine storm syndrome, organ dysfunction, and death. Considering that neutrophil extracellular traps (NETs) have been described as important mediators of tissue damage in inflammatory diseases, we investigated whether NETs would be involved in COVID-19 pathophysiology. A cohort of 32 hospitalized patients with a confirmed diagnosis of COVID-19 and healthy controls were enrolled. The concentration of NETs was augmented in plasma, tracheal aspirate, and lung autopsies tissues from COVID-19 patients, and their neutrophils released higher levels of NETs. Notably, we found that viable SARS-CoV-2 can directly induce the release of NETs by healthy neutrophils. Mechanistically, NETs triggered by SARS-CoV-2 depend on angiotensin-converting enzyme 2, serine protease, virus replication, and PAD-4. Finally, NETs released by SARS-CoV-2-activated neutrophils promote lung epithelial cell death in vitro. These results unravel a possible detrimental role of NETs in the pathophysiology of COVID-19. Therefore, the inhibition of NETs represents a potential therapeutic target for COVID-19.


Subject(s)
Betacoronavirus/physiology , Coronavirus Infections/immunology , Coronavirus Infections/virology , Extracellular Traps/physiology , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , A549 Cells , Adult , Angiotensin-Converting Enzyme 2 , COVID-19 , Cell Death , Coronavirus Infections/blood , Coronavirus Infections/pathology , Epithelial Cells/pathology , Epithelial Cells/virology , Female , HeLa Cells , Humans , Male , Neutrophil Activation , Pandemics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/blood , Pneumonia, Viral/pathology , SARS-CoV-2 , Serine Proteases/metabolism , Suction , Trachea/immunology
18.
Tuberculosis (Edinb) ; 124: 101980, 2020 09.
Article in English | MEDLINE | ID: mdl-32801053

ABSTRACT

Tuberculosis (TB) is the leading cause of mortality among infectious diseases worldwide. The study of molecular targets for therapy and diagnosis suggested that Notch signaling is an important pathway for the maintenance of the immune response during Mycobacterium tuberculosis (Mtb) infection. We evaluated the participation of the Notch pathway in the modulation of immune response during Mtb infection, and observed that patients with active TB had increased DLL4 expression in intermediate and non-classic monocytes. Further, patients with moderate and advanced lung injury have higher Notch1 expression in CD4+ T cells when compared to patients with a minimal lung injury. When we considered the severity of disease in active TB patients, the expression of the DLL4 in intermediate monocytes and the expression of Notch1 in CD4+ T cells are positively correlated with the degree of lung injury. In vitro, PBMCs treated with the Notch pharmacological inhibitor reduced the production of IL-17A and IL-2, whereas anti-hDLL4 treatment promoted a significant increase in TNF-α and phagocytosis. We suggest that Notch1 and DLL4 are associated with immune response activation in human tuberculosis, and can be a novel target to be exploited in the future in the searching of biomarkers.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , CD4-Positive T-Lymphocytes/metabolism , Calcium-Binding Proteins/metabolism , Lung/metabolism , Mycobacterium tuberculosis/immunology , Receptor, Notch1/metabolism , Tuberculosis, Pulmonary/metabolism , Adult , Biomarkers/metabolism , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/microbiology , Case-Control Studies , Cells, Cultured , Cytokines/metabolism , Disease Progression , Female , Host-Pathogen Interactions , Humans , Lung/immunology , Lung/microbiology , Male , Middle Aged , Phagocytosis , Severity of Illness Index , Signal Transduction , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology , Young Adult
19.
Preprint in English | medRxiv | ID: ppmedrxiv-20169573

ABSTRACT

IntroductionNeutrophilia and high levels of proinflammatory cytokines and other mediators of inflammation are common finds in patients with severe acute respiratory syndrome due to COVID-19. By its action on leukocytes, we propose colchicine as an intervention worthy of being tested. ObjectiveTo evaluate whether the addition of colchicine to standard treatment for COVID-19 results in better outcomes. MethodsWe present the interim analysis of a single-center randomized, double-blinded, placebo controlled clinical trial of colchicine for the treatment of moderate to severe COVID-19, with 38 patients allocated 1:1 from April 11 to July 06, 2020. Colchicine regimen was 0.5 mg thrice daily for 5 days, then 0.5 mg twice daily for 5 days. The first dose was 1.0 mg whether body weight was [≥] 80 kg. EndpointsThe primary endpoints were the need for supplemental oxygen; time of hospitalization; need for admission and length of stay in intensive care units; and death rate and causes of mortality. As secondary endpoints, we assessed: serum C-reactive protein, serum Lactate dehydrogenase and relation neutrophil to lymphocyte of peripheral blood samples from day zero to day 7; the number, type, and severity of adverse events; frequency of interruption of the study protocol due to adverse events; and frequency of QT interval above 450 ms. ResultsThirty-five patients (18 for Placebo and 17 for Colchicine) completed the study. Both groups were comparable in terms of demographic, clinical and laboratory data at baseline. Median (and interquartile range) time of need for supplemental oxygen was 3.0 (1.5-6.5) days for the Colchicine group and 7.0 (3.0-8.5) days for Placebo group (p = 0.02). Median (IQR) time of hospitalization was 6.0 (4.0-8.5) days for the Colchicine group and 8.5 (5.5-11.0) days for Placebo group (p = 0.03). At day 2, 53% vs 83% of patients maintained the need for supplemental oxygen, while at day 7 the values were 6% vs 39%, in the Colchicine and Placebo groups, respectively (log rank; p = 0.01). Hospitalization was maintained for 53% vs 78% of patients at day 5 and 6% vs 17% at day 10, for the Colchicine and Placebo groups, respectively (log rank; p = 0.01). One patient per group needed admission to ICU. No recruited patient died. At day 4, patients of Colchicine group presented significant reduction of serum C-reactive protein compared to baseline (p < 0.001). The majority of adverse events were mild and did not lead to patient withdrawal. Diarrhea was more frequent in the Colchicine group (p = 0.17). Cardiac adverse events were absent. DiscussionThe use of colchicine reduced the length of supplemental oxygen therapy and the length of hospitalization. Clinical improvement was in parallel with a reduction on serum levels of C-reactive protein. The drug was safe and well tolerated. Colchicine may be considered a beneficial and not expensive option for COVID-19 treatment. Clinical trials with larger numbers of patients should be conducted to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for hospitalized patients with moderate to severe COVID-19.

SELECTION OF CITATIONS
SEARCH DETAIL
...